Search Results

222,790 Results for "abgenomics corporation".

Sort By

Drug Development

AltruBio Raises $225M in Series B to Advance Ulcerative Colitis Candidate

Formerly known as AbGenomics Holding, AltruBio on Tuesday said it will use the funds to push its ulcerative colitis asset into a Phase IIb trial with an anticipated readout in 2026.

May 21, 2024
·
2 min read
·
Tyler Patchen
Press Releases

Kelyniam Corporate Update

January 21, 2025
·
2 min read
Press Releases

Positron Corporation Engages Skyline Corporate Communications Group, LLC to Enhance Investor Relations and Financial Community Outreach

January 14, 2025
·
4 min read
Press Releases

Optimi Health Provides Corporate Update

Non-Brokered Private Placement and Debt Settlement

January 17, 2025
·
5 min read
Press Releases

Arbutus Provides 2025 Corporate and Financial Update

January 14, 2025
·
11 min read
Press Releases

Aridis Provides Corporate Update

December 20, 2024
·
9 min read
Press Releases

PureTech Appoints UBS as UK Corporate Broker

January 6, 2025
·
1 min read
Deals

Atrion Corporation Enters Into Merger Agreement with Nordson Corporation

Atrion Corporation (NASDAQ: ATRI), a developer and manufacturer of products primarily for medical applications, today announced that it has entered into an agreement and plan of merger with Nordson Corporation pursuant to which Nordson will acquire Atrion for $460 per share in cash, representing a total equity value of approximately $815 million.

May 28, 2024
·
9 min read
Press Releases

Cytokinetics Announces 2025 Corporate Milestones and Vision 2030

January 14, 2025
·
7 min read
Press Releases

Xenon Outlines Key Corporate Milestone Opportunities for 2025

January 13, 2025
·
7 min read